Abstract:Myelin is the lipidic insulating structure enwrapping axons and allowing fast saltatory nerve conduction. In the central nervous system, myelin sheath is the result of the complex packaging of multilamellar extensions of oligodendrocyte (OL) membranes. Before reaching myelinating capabilities, OLs undergo a very precise program of differentiation and maturation that starts from OL precursor cells (OPCs). In the last 20 years, the biology of OPCs and their behavior under pathological conditions have been studied through several experimental models. When co-cultured with neurons, OPCs undergo terminal maturation and produce myelin tracts around axons, allowing to investigate myelination in response to exogenous stimuli in a very simple in vitro system. On the other hand, in vivo models more closely reproducing some of the features of human pathophysiology enabled to assess the consequences of demyelination and the molecular mechanisms of remyelination, and they are often used to validate the effect of pharmacological agents. However, they are very complex, and not suitable for large scale drug discovery screening. Recent advances in cell reprogramming, biophysics and bioengineering have allowed impressive improvements in the methodological approaches to study brain physiology and myelination. Rat and mouse OPCs can be replaced by human OPCs obtained by induced pluripotent stem cells (iPSCs) derived from healthy or diseased individuals, thus offering unprecedented possibilities for personalized disease modeling and treatment. OPCs and neural cells can be also artificially assembled, using 3D-printed culture chambers and biomaterial scaffolds, which allow modeling cell-to-cell interactions in a highly controlled manner. Interestingly, scaffold stiffness can be adopted to reproduce the mechanosensory properties assumed by tissues in physiological or pathological conditions. Moreover, the recent development of iPSC-derived 3D brain cultures, called organoids, has made it possible to study key aspects of embryonic brain development, such as neuronal differentiation, maturation and network formation in temporal dynamics that are inaccessible to traditional in vitro cultures. Despite the huge potential of organoids, their application to myelination studies is still in its infancy. In this review, we shall summarize the novel most relevant experimental approaches and their implications for the identification of remyelinating agents for human diseases such as multiple sclerosis.

Periods of synchronized myelin changes shape brain function and plasticity

Dynamics of mature myelin

Myelin: A gatekeeper of activity-dependent circuit plasticity?

Functional myelin in cognition and neurodevelopmental disorders

Oligodendrocytes: Myelination, Plasticity, and Axonal Support

Myelination dictates axonal viscoelasticity

Myelin development, plasticity, and pathology in the auditory system

Oligodendrocytes and myelin limit neuronal plasticity in visual cortex

Axonal neurotransmitter release in the regulation of myelination

Brain-wide mapping of oligodendrocyte organization and oligodendrogenesis across the murine lifespan

Clinical implications of myelin regeneration in the central nervous system

Clinical Applications of Myelin Plasticity for Remyelinating Therapies in Multiple Sclerosis

Schema-like learning and memory consolidation acting through myelination

Translating Molecular Approaches to Oligodendrocyte-Mediated Neurological Circuit Modulation

Epigenetic regulation of oligodendrocyte myelination in developmental disorders and neurodegenerative diseases.

Integrative Systems and Functional Analyses Reveal a Role of Dopaminergic Signaling in Myelin Pathogenesis.

Novel in vitro Experimental Approaches to Study Myelination and Remyelination in the Central Nervous System

Microglia regulate central nervous system myelin growth and integrity

Localized microglia dysregulation impairs central nervous system myelination in development

The development of brain white matter microstructure

Refinement of axonal conduction and myelination in the mouse optic nerve indicate an extended period of postnatal developmental plasticity